Anagliptin, a potent dipeptidyl peptidase IV inhibitor: its single-crystal structure and enzyme interactions

被引:43
作者
Watanabe, Yukihisa S. [1 ]
Yasuda, Yoshika [1 ]
Kojima, Yuko [2 ]
Okada, Shino [3 ]
Motoyama, Tomoko [3 ]
Takahashi, Ryo [4 ]
Oka, Mitsuru [1 ]
机构
[1] Sanwa Kagaku Kenkyusho Co Ltd, Mie Res Pk, 363 Shiosaki,Hokusei Cho, Inabe, Mie 5110406, Japan
[2] Mitsubishi Chem Grp Sci & Technol Res Ctr Inc, Yokohama Lab, Yokohama, Kanagawa, Japan
[3] Sosho Inc, Osaka, Japan
[4] Sysmex Corp, Kobe, Hyogo, Japan
关键词
Co-crystal structure; DPP-4; inhibitor; transition-state interaction; type; 2; diabetes; X-ray crystallography; HIGHLY POTENT; ACTIVE-SITE; DISCOVERY; COMPLEX; MODEL; IV/CD26;
D O I
10.3109/14756366.2014.1002402
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The single-crystal structure of anagliptin, N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}-amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a] pyrimidine-6-carboxamide, was determined. Two independent molecules were held together by intermolecular hydrogen bonds, and the absolute configuration of the 2-cyanopyrrolidine ring delivered from L-prolinamide was confirmed to be S. The interactions of anagliptin with DPP-4 were clarified by the co-crystal structure solved at 2.85 angstrom resolution. Based on the structure determined by X-ray crystallography, the potency and selectivity of anagliptin were discussed, and an SAR study using anagliptin derivatives was performed.
引用
收藏
页码:981 / 988
页数:8
相关论文
共 33 条
[1]   Laser irradiated growth of protein crystal [J].
Adachi, H ;
Takano, K ;
Hosokawa, Y ;
Inoue, T ;
Mori, Y ;
Matsumura, H ;
Yoshimura, M ;
Tsunaka, Y ;
Morikawa, M ;
Kanaya, S ;
Masuhara, H ;
Kai, Y ;
Sasaki, T .
JAPANESE JOURNAL OF APPLIED PHYSICS PART 2-LETTERS & EXPRESS LETTERS, 2003, 42 (7B) :L798-L800
[2]   Synthesis and biological evaluation of homopiperazine derivatives with β-aminoacyl group as dipeptidyl peptidase IV inhibitors [J].
Ahn, Jin Hee ;
Park, Woul Seong ;
Jun, Mi Ae ;
Shin, Mi Sik ;
Kang, Seung Kyu ;
Kim, Ki Young ;
Dal Rhee, Sang ;
Bae, Myung Ae ;
Kim, Kwang Rok ;
Kim, Sung Gyu ;
Kim, Sun Young ;
Sohn, Sang Kwon ;
Kang, Nam Sook ;
Lee, Jie Oh ;
Lee, Duck Hyung ;
Cheon, Hyae Gyeong ;
Kim, Sung Soo .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (24) :6525-6529
[3]  
[Anonymous], GLID VERS 6 1
[4]  
Burkey BF, 2006, 42 EASD M COP DENM 2
[5]   Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig [J].
Deacon, CF ;
Hughes, TE ;
Holst, JJ .
DIABETES, 1998, 47 (05) :764-769
[6]   Rigidity and flexibility of dipeptidyl peptidase IV: Crystal structures of and docking experiments with DPIV [J].
Engel, M ;
Hoffmann, T ;
Manhart, S ;
Heiser, U ;
Chambre, S ;
Huber, R ;
Demuth, HU ;
Bode, W .
JOURNAL OF MOLECULAR BIOLOGY, 2006, 355 (04) :768-783
[7]   The crystal structure of dipeptidyl peptidase IV(CD26) reveals its functional regulation and enzymatic mechanism [J].
Engel, M ;
Hoffmann, T ;
Wagner, L ;
Wermann, M ;
Heiser, U ;
Kiefersauer, R ;
Huber, R ;
Bode, W ;
Demuth, HU ;
Brandstetter, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (09) :5063-5068
[8]   Discovery of alogliptin: A potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV [J].
Feng, Jun ;
Zhang, Zhiyuan ;
Wallace, Michael B. ;
Stafford, Jeffrey A. ;
Kaldor, Stephen W. ;
Kassel, Daniel B. ;
Navre, Marc ;
Shi, Lihong ;
Skene, Robert J. ;
Asakawa, Tomoko ;
Takeuchi, Koji ;
Xu, Rongda ;
Webb, David R. ;
Gwaltney, Stephen L., II .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (10) :2297-2300
[9]   ON ENANTIOMORPH-POLARITY ESTIMATION [J].
FLACK, HD .
ACTA CRYSTALLOGRAPHICA SECTION A, 1983, 39 (NOV) :876-881
[10]   Pharmacokinetics and metabolism of [14C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans [J].
Furuta, Shinji ;
Smart, Clair ;
Hackett, Andrew ;
Benning, Rajdeep ;
Warrington, Steve .
XENOBIOTICA, 2013, 43 (05) :432-442